Gum surgery combo shows promise for regrowing bone in periodontitis patients
NCT ID NCT07233733
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a gum surgery that combines a connective tissue graft with a special protein gel (enamel matrix derivative) to help regrow bone and gum tissue in people with advanced gum disease. Seventeen adults with deep gum pockets received the treatment, and researchers measured improvements in bone fill, gum attachment, and tissue stability over six months. The goal was to see if this approach leads to better healing and gum appearance compared to the patient's starting condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
17 people
The number who actually took part.
- Started
-
Jun 2024
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults ≥18 years old who can provide written informed consent. * Diagnosis of stage III-IV periodontitis (2017 World Workshop). * Completed initial non-surgical periodontal therapy with good plaque control. * Full-mouth plaque score (FMPS) ≤20% and full-mouth bleeding score (FMBS) ≤20%. * Presence of ≥1 intrabony periodontal defect with an intrabony component ≥3 mm, confirmed clinically and radiographically. * Probing pocket depth (PPD) at the study site ≥6 mm. Exclusion Criteria: * Systemic conditions or medications that could affect periodontal healing (e.g., diabetes mellitus, immunodeficiency, bisphosphonates, corticosteroids, immunosuppressants). * Current smokers or former heavy smokers. * Pregnancy or lactation. * Teeth with untreated endodontic lesions or non-vital status; furcation involvement class II-III. * Untreated occlusal trauma or tooth mobility grade II-III. * Third molars.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Periodontal diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Medicine and Pharmacy at Ho Chi Minh City - Faculty of Odonto-Stomatology
Ho Chi Minh City, Ho Chi Minh City, 700000, Vietnam
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a pill replace an IV for gum surgery pain relief?
- Can everyday supplements boost gum disease therapy?
- Can pulling a loose tooth and putting it back save it?
- Gum fluid proteins eyed as link between smoking and periodontitis
- Gum fluid holds clues to Behçet's disease puzzle
- Magnifying the fight against gum disease: loupe vs microscope